We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genomic Study Identifies Risk Regions for Intrahepatic Cholestasis of Pregnancy

By LabMedica International staff writers
Posted on 20 Jun 2026

Intrahepatic cholestasis of pregnancy (ICP) affects 0. More...

2–2% of pregnancies and typically arises after 30 weeks, presenting with intense itching of the palms and soles. Diagnosis is confirmed by elevated liver enzymes and increased serum bile acids, and the condition is linked to higher risks of preterm birth and stillbirth. Although genetic susceptibility has been suspected, the underlying mechanisms have been unclear. New findings demonstrate that large-scale human genetic analyses have identified multiple regions associated with ICP.

Tampere University led an international genome-wide meta-analysis that combined genetic data from more than 4,700 women with a history of ICP and over 436,000 control women from Finland, Iceland, Estonia and Denmark. The study identified 26 genetic regions associated with ICP, including 10 not previously reported. Genes within these regions influence hepatic handling of bile acids, fats and cholesterol, aligning ICP susceptibility with broader disturbances in liver metabolism during pregnancy-related hormonal changes.

The investigators also examined clinical associations beyond pregnancy. Women with prior ICP showed an increased risk of hepatobiliary disorders, including fatty liver disease, gallstones and inflammation of the bile ducts, as well as higher rates of certain autoimmune diseases such as Crohn’s disease, thyroid disorders and type 2 diabetes. Analyses further suggested a possible shared genetic basis between ICP and pancreatitis.

The findings were published in Nature Communications on May 25, 2026. According to the study authors, the results hold promise for identifying at‑risk groups, improving diagnosis and treatment, and supporting the early identification of related conditions. The work involved researchers affiliated with Tampere University and the University of Oulu.

"Our analyses also suggested a possible shared genetic basis between ICP and pancreatitis, which is inflammation of the pancreas, meaning that the same genetic susceptibility may increase the risk of both conditions. This is a new discovery that, to our knowledge, has not been reported previously. However, further studies are needed to better understand this connection," said Jaakko Tyrmi, postdoctoral research fellow at Tampere University and the University of Oulu.

Related Links
Tampere University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image:Geographic distribution of the survey respondents. (Cavalier E, Kapoula G, Bhattoa HP, et al. IOF-IFCC international survey of global laboratory practices for bone status indices. Clin Chem Lab Med. 2026. DOI:10.1515/cclm-2026-0941.)

Global Laboratory Survey Underscores Need to Standardize Bone Biomarker Testing

Bone and mineral metabolism biomarkers can complement dual-energy X-ray absorptiometry (DXA) by providing information on disease activity and treatment response. For more than 20 years, standardization... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.